Ph.D DSc (Hon) FMedSci
Visiting Professor of Pharmacology/Honorary Business Development Advisor, Imperial College, London
Dr Hill has worked extensively across the pharmaceutical industry and academia in pharmacology and neuroscience. Before his retirement from Merck at the end of April 2008, he headed a group within the company aimed at establishing beneficial relationships with European pharmaceutical companies, biotechs and academic institutions across therapeutic areas and platform technologies. Dr Hill has published more than 200 peer reviewed papers on the pharmacology of opioids and other analgesic drugs and on the role of substance P, CGRP, bradykinin and other peptides in emesis, nociception and the control of food intake. He has several non-executive, academic and public sector roles.